Kaplan & Sadock’s Concise Textbook of Clinical Psychiatry 5th Edition by Robert Boland, ISBN-13: 978-1975167486

Trustpilot

Kaplan & Sadock’s Concise Textbook of Clinical Psychiatry 5th Edition by Robert Boland, ISBN-13: 978-1975167486

[PDF eBook eTextbook] – Available Instantly

• Publisher: ‎ LWW; Fifth edition (March 22, 2022)
• Language: ‎ English
• ISBN-10: ‎ 1975167481
• ISBN-13: ‎ 978-1975167486

Succinct, authoritative, and affordable, Kaplan & Sadock’s Concise Textbook of Psychiatry, 5th Edition, provides must-know information in clinical psychiatry from the names you trust. From cover to cover, it contains the most relevant clinical material from the bestselling Kaplan and Sadock’s Synopsis of Psychiatry 12th Edition, including the foundational chapters on assessment, the disorder specific chapters, and all of the treatment-specific chapters among other essential topics such as emergency psychiatry, ethics, and palliative/end-of-life care. New editors Robert Boland and Marcia L. Verduin, along with consulting editor Pedro Ruiz, have updated all content with a focus on reformatting and summarizing for faster access to key information.

– Provides concise but thorough coverage of the entire field of clinical psychiatry, including biologic, psychologic, and sociologic factors in health and disease.

– Offers step-by-step guidance on the clinical examination, the psychiatric report, medical assessment of the psychiatric patient, laboratory tests, and signs and symptoms, as well as all psychiatric and substance-related disorders, with special chapters on children, adolescents, and the elderly.

– Presents the most current treatment methods including descriptions of all modern psychotherapeutic techniques.

– Contains real-world case histories throughout and features a unique glossary of psychiatric signs and symptoms.

– Includes thorough updates and revisions throughout, all consistent with the DSM-5.

– Presents a comprehensive overview of the clinical aspects of psychiatry for clinicians, residents, students, and all others who provide mental health care.

Table of Contents:

Cover
Title Page
Copyright
Dedication
Preface
Contents
About the Authors
A Clinical Psychiatry
1. Examination and Diagnosis of the Psychiatric Patient
1.1 The Adult Patient
PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION
PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT
THE PSYCHIATRIC REPORT AND MEDICAL RECORD
PSYCHIATRIC RATING SCALES
CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS
PERSONALITY ASSESSMENT: ADULTS AND CHILDREN
MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY
NEUROIMAGING
1.2 Children and Adolescents
CLINICAL INTERVIEWS
DIAGNOSTIC INSTRUMENTS
QUESTIONNAIRES AND RATING SCALES
COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION
INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS
1.3 Geriatric Patients
PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT
EARLY DETECTION AND PREVENTION STRATEGIES
2. Neurodevelopmental Disorders and Other Childhood Disorders
2.1 Intellectual Disability
NOMENCLATURE
CLASSIFICATION
DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY
CLINICAL FEATURES
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
2.2 Communication Disorders
LANGUAGE DISORDER
SPEECH SOUND DISORDER
CHILD-ONSET FLUENCY DISORDER (STUTTERING)
SOCIAL (PRAGMATIC) COMMUNICATION DISORDER
UNSPECIFIED COMMUNICATION DISORDER
2.3 Autism Spectrum Disorder
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY AND PATHOGENESIS
2.4 Attention-Deficit/Hyperactivity Disorder
CLINICAL FEATURES
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
ADULT MANIFESTATIONS OF ADHD
2.5 Specific Learning Disorder
SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING
SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS
SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION
2.6 Motor Disorders
DEVELOPMENTAL COORDINATION DISORDER
STEREOTYPIC MOVEMENT DISORDER
TOURETTES DISORDER
PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER
2.7 Feeding and Eating Disorders of Infancy or Early Childhood
PICA
RUMINATION DISORDER
AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER
2.8 Trauma- and Stressor-Related Disorders in Children
REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER
POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE
2.9 Depressive Disorders and Suicide in Children and Adolescents
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
SUICIDE
2.10 Early-Onset Bipolar Disorder
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
2.11 Disruptive Mood Dysregulation Disorder
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
2.12 Disruptive Behaviors of Childhood
OPPOSITIONAL DEFIANT DISORDER
CONDUCT DISORDER
2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)
SEPARATION ANXIETY DISORDER
GENERALIZED ANXIETY DISORDER
SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA)
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
2.14 Selective Mutism
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
2.16 Early-Onset Schizophrenia
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
ATTENUATED PSYCHOSIS SYNDROME
2.17 Adolescent Substance Use Disorders
DIAGNOSIS AND CLINICAL FEATURES
COMORBIDITY
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
3. Neurocognitive Disorders
DEFINITION
CLINICAL EVALUATION
PATHOLOGY AND LABORATORY EXAMINATION
3.1 Delirium
DIAGNOSIS AND CLINICAL FEATURES
PHYSICAL AND LABORATORY EXAMINATIONS
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
3.2 Dementia (Major Neurocognitive Disorder)
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders)
DIAGNOSIS
CLINICAL FEATURES AND SUBTYPES
PATHOLOGY AND LABORATORY EXAMINATION
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition
SPECIFIC DISORDERS
3.5 Mild Cognitive Impairment
DEFINITION
CLINICAL PRESENTATION
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY AND ETIOLOGY OF MCI
4. Substance Use and Addictive Disorders
4.1 General Features of the Substance-Related Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
COMORBIDITY
TREATMENT APPROACH
ETIOLOGY
4.2 Alcohol-Related Disorders
DIAGNOSIS AND CLINICAL FEATURES
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT OF ALCOHOL USE DISORDERS
PATHOLOGY
ETIOLOGY
4.3 Cannabis-Related Disorders
CLINICAL FEATURES
DIAGNOSIS
COMORBIDITY
TREATMENT AND REHABILITATION
EPIDEMIOLOGY
PATHOLOGY
4.4 Opioid-Related Disorders
CLINICAL FEATURES
COMORBIDITY
TREATMENT AND REHABILITATION
EPIDEMIOLOGY
PATHOLOGY
ETIOLOGY
4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
DIAGNOSIS
TREATMENT AND REHABILITATION
EPIDEMIOLOGY
PATHOLOGY
4.6 Stimulant-Related Disorders
CLINICAL FEATURES
DIAGNOSIS
COMORBIDITY
TREATMENT AND REHABILITATION
EPIDEMIOLOGY
PATHOLOGY
ETIOLOGY
4.7 Tobacco-Related Disorders
CLINICAL FEATURES
DIAGNOSIS
TREATMENT
EPIDEMIOLOGY
PATHOLOGY
4.8 Caffeine-Related Disorders
CLINICAL FEATURES AND DIAGNOSIS
COMORBIDITY
TREATMENT
EPIDEMIOLOGY
PATHOLOGY AND ETIOLOGY
4.9 Hallucinogen-Related Disorders
CLINICAL FEATURES
DIAGNOSIS
TREATMENT
EPIDEMIOLOGY
PATHOLOGY
4.10 Inhalant-Related Disorders
CLINICAL FEATURES
DIAGNOSIS
TREATMENT
EPIDEMIOLOGY
4.11 Anabolic-Androgenic Steroid Use
CLINICAL FEATURES AND DIAGNOSIS
TREATMENT
EPIDEMIOLOGY
PATHOLOGY
ETIOLOGY
4.12 Gambling Disorder
CLINICAL FEATURES
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
4.13 Other Disorders Related to the Addictive Disorders
INTERNET GAMING DISORDER
MOBILE OR CELL PHONE COMPULSION
REPETITIVE SELF-MUTILATION
COMPULSIVE SEXUAL BEHAVIOR
5. Schizophrenia Spectrum and Other Psychotic Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
OBJECTIVE TESTS FOR THE DISORDER
DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS
COMORBIDITY
COURSE
PROGNOSIS
TREATMENT APPROACH
THE EPIDEMIOLOGY OF THE DISORDERS
THE NEUROBIOLOGY OF THE DISORDER
THE PSYCHOLOGY OF THE DISORDER
ETIOLOGY
6. Bipolar Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE
PROGNOSIS
TREATMENT APPROACH
THE EPIDEMIOLOGY OF THE DISORDER(S)
THE NEUROBIOLOGY OF THE DISORDER
THE PSYCHOLOGY OF THE DISORDER
ETIOLOGY
7. Depressive Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE
PROGNOSIS
TREATMENT APPROACH
THE EPIDEMIOLOGY OF DEPRESSION
THE NEUROBIOLOGY OF DEPRESSION
THE PSYCHOLOGY OF DEPRESSION
ETIOLOGY
8. Anxiety Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE
TREATMENT APPROACH
THE EPIDEMIOLOGY OF THE DISORDER(S)
THE NEUROBIOLOGY OF THE DISORDER
ETIOLOGY
9. Obsessive-Compulsive and Related Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
10. Trauma- and Stressor-Related Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT APPROACH
EPIDEMIOLOGY
ETIOLOGY
11. Dissociative Disorders
DIAGNOSTIC AND CLINICAL FEATURES
DEPERSONALIZATION/DEREALIZATION DISORDER
DISSOCIATIVE IDENTITY DISORDER
OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
12. Somatic Symptom and Related Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS
EPIDEMIOLOGY
ETIOLOGY
13. Feeding and Eating Disorders
CLINICAL FEATURES
DIAGNOSIS AND CLINICAL FEATURES
PATHOLOGY AND LABORATORY EXAMINATION
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT APPROACH
EPIDEMIOLOGY
ETIOLOGY
14. Elimination Disorders
ENCOPRESIS
ENURESIS
15. Sleep–Wake Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
CLINICAL TOOLS IN SLEEP MEDICINE
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
TREATMENT APPROACH
16. Human Sexuality and Sexual Dysfunctions
SEXUAL DYSFUNCTIONS
PARAPHILIC DISORDERS
SEX ADDICTION AND COMPULSIVITY
NORMAL SEXUALITY
17. Gender Dysphoria, Gender Identity, and Related Conditions
INTRODUCTION
DIAGNOSIS AND CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
COURSE AND PROGNOSIS
COMORBIDITY
TREATMENT
EPIDEMIOLOGY
ETIOLOGY
18. Disruptive, Impulse-Control, and Conduct Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
OBJECTIVE TESTS FOR THE DISORDERS
DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT APPROACH
EPIDEMIOLOGY
ETIOLOGY
19. Personality Disorders
THE CLINICAL PRESENTATION
DIAGNOSIS
DIFFERENTIAL DIAGNOSIS
COMORBIDITY
COURSE AND PROGNOSIS
TREATMENT APPROACH
EPIDEMIOLOGY
ETIOLOGY
20. Other Conditions that May be a Focus of Clinical Attention
INTRODUCTION
MALINGERING
BEREAVEMENT
OCCUPATIONAL PROBLEMS
ADULT ANTISOCIAL BEHAVIOR
RELIGIOUS OR SPIRITUAL PROBLEM
ACCULTURATION PROBLEM
PHASE OF LIFE PROBLEM
NONCOMPLIANCE WITH TREATMENT
RELATIONAL PROBLEMS
B Treatment Across the Lifespan
21. Psychopharmacology
DRUG SELECTION
DRUG FACTORS
SIDE EFFECTS
PATIENT-RELATED FACTORS
INFORMED CONSENT AND PATIENT EDUCATION
DOSING, DURATION, AND MONITORING
LABORATORY TESTS AND THERAPEUTIC BLOOD MONITORING
TREATMENT OUTCOMES
COMBINATION OF DRUGS
COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY
SPECIAL POPULATIONS
REGULATORY ISSUES
NONAPPROVED DOSAGES AND USES
PLACEBOS
21.1 Antipsychotics
SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS)
DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS)
21.2 Antidepressants
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS
BUPROPION
MIRTAZAPINE
NEFAZODONE AND TRAZODONE
TRICYCLICS AND TETRACYCLICS
MONOAMINE OXIDASE INHIBITORS
THYROID HORMONES
NOVEL AGENTS
21.3 Mood Stabilizers
LITHIUM
VALPROATE
LAMOTRIGINE
CARBAMAZEPINE AND OXCARBAZEPINE
OTHER ANTICONVULSANTS
CALCIUM CHANNEL BLOCKERS
21.4 Anxiolytics
BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS
BUSPIRONE
β-Adrenergic Receptor Antagonists
BARBITURATES AND SIMILARLY ACTING DRUGS
21.5 Drugs Used to Treat Sleep Disorders
NONBENZODIAZEPINE GABA AGONISTS
MELATONIN AGONISTS: RAMELTEON AND MELATONIN
PRAZOSIN
21.6 Stimulants
STIMULANT DRUGS AND ATOMOXETINE
ATOMOXETINE (STRATTERA)
21.7 Drugs Used to Treat Substance Use Disorders
OPIOID RECEPTOR AGONISTS
OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE
DISULFIRAM AND ACAMPROSATE
CLONIDINE AND GUANFACINE
21.8 Drugs Used for Cognitive Enhancement
CHOLINESTERASE INHIBITORS
MEMANTINE
21.9 Drugs Used to Treat Sexual Disorders
PHOSPHODIESTERASE-5 INHIBITORS
YOHIMBINE
21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs
ANTICHOLINERGIC AGENTS
ANTIHISTAMINES
DOPAMINE RECEPTOR AGONISTS AND PRECURSORS
DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN
21.11 Nutritional Supplements and Related
NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS
PHYTOMEDICINES
22. Other Somatic Therapies
ELECTROCONVULSIVE THERAPY
OTHER BRAIN STIMULATION METHODS
NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION
23. Psychotherapy
PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY
BRIEF PSYCHODYNAMIC PSYCHOTHERAPY
GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA
FAMILY THERAPY AND COUPLES THERAPY
DIALECTICAL BEHAVIOR THERAPY
BIOFEEDBACK
COGNITIVE THERAPY
BEHAVIOR THERAPY
HYPNOSIS
INTERPERSONAL THERAPY
NARRATIVE PSYCHOTHERAPY
COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY
MENTALIZATION-BASED TREATMENT
PSYCHOEDUCATIONAL INTERVENTIONS
24. Psychiatric Rehabilitation and Other Interventions
PSYCHIATRIC REHABILITATION
GENETIC COUNSELING
25. Consultation to Other Disciplines
25.1 Consultation-Liaison Psychiatry
HISTORY
CURRENT TRENDS
EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE
TREATMENTS USED IN PSYCHOSOMATIC MEDICINE
PSYCHO-ONCOLOGY
25.2 Geriatric Psychiatry
PSYCHIATRIC PROBLEMS OF OLDER PERSONS
MENTAL DISORDERS OF OLD AGE
SUICIDE RISK
OTHER CONDITIONS OF OLD AGE
SPOUSAL BEREAVEMENT
PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS
PSYCHOTHERAPY FOR GERIATRIC PATIENTS
25.3 Psychiatric Emergencies
TREATMENT SETTINGS
EPIDEMIOLOGY
EVALUATION
SPECIFIC INTERVIEW SITUATIONS
TREATMENT OF EMERGENCIES
PSYCHIATRIC EMERGENCIES IN CHILDREN
26. Level of Care
INPATIENT ADMISSION
PARTIAL HOSPITAL TREATMENT
INTENSIVE OUTPATIENT TREATMENT
OUTPATIENT CARE
RESIDENTIAL CARE
C Other Issues Relevant to Psychiatry
27. Ethics and Professionalism
PROFESSIONAL CODES
BASIC ETHICAL PRINCIPLES
SPECIFIC ISSUES
28. Forensic and Legal Issues
MEDICAL MALPRACTICE
PRIVILEGE AND CONFIDENTIALITY
HIGH-RISK CLINICAL SITUATIONS
HOSPITALIZATION
RIGHT TO TREATMENT
RIGHT TO REFUSE TREATMENT
CIVIL RIGHTS OF PATIENTS
SECLUSION AND RESTRAINT
INFORMED CONSENT
CHILD CUSTODY
TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE
CRIMINAL LAW
OTHER AREAS OF FORENSIC PSYCHIATRY
29. End-of-Life Issues and Palliative Care
29.1 Death, Dying, and Bereavement
DEATH AND DYING
BEREAVEMENT, GRIEF, AND MOURNING
LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT
29.2 Palliative Care
PREVALENCE
GENERAL TREATMENT PRINCIPLES
ANXIETY IN PATIENTS WITH ADVANCED DISEASE
DEPRESSION IN PATIENTS WITH ADVANCED DISEASE
CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE
DISEASE-SPECIFIC CONSIDERATIONS
PATIENT–FAMILY UNIT
DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES
CARING FOR THE DYING PATIENT
COMMUNICATION
TERMINAL CARE DECISIONS
CARING FOR THE FAMILY
PALLIATIVE CARE
PAIN MANAGEMENT
PALLIATION OF OTHER SYMPTOMS
HOSPICE CARE
NEONATAL AND INFANT END-OF-LIFE CARE
CHILD END-OF-LIFE CARE
SPIRITUAL ISSUES
ALTERNATIVE AND COMPLEMENTARY MEDICINE
29.3 Euthanasia and Physician-Assisted Suicide
EUTHANASIA
PHYSICIAN-ASSISTED SUICIDE
FUTURE DIRECTIONS
30. Community Psychiatry
INTRODUCTION
CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY
THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE
31. Global and Cultural Issues in Psychiatry
PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE
TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE
RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE
PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE
STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS
RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES
ETHICAL ISSUES IN MENTAL HEALTH CARE
INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD
FUTURE PERSPECTIVES
Glossary of Terms Relating to Signs and Symptoms
Index

In addition to being chief of staff and senior vice president at Menninger, Robert J. Boland, MD, is executive vice chair of the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine (BCM) and the Brown Foundation Endowed Chair in Psychiatry at BCM. He is responsible for the clinical care, research and education provided at The Clinic.

Prior to coming to Menninger, he served as vice chair of education and director of the psychiatry residency program at Brigham and Women’s Hospital and as an associate professor of psychiatry at Harvard Medical School. Board certified in psychiatry with expertise in medical education, psychosomatic medicine and geriatric psychiatry, he is an alumnus of Georgetown University where he earned his undergraduate and medical degrees.

Prior to joining Brigham and Women’s Hospital, Dr. Boland had an 18-year tenure at the Alpert School of Medicine at Brown University, Providence, R.I. He developed a special interest in depression resulting from medical illness and, later participated in the National Institute of Mental Health-sponsored Collaborative Depression Study. That project remains one of the longest studies of depression to date, for which Dr. Boland has written widely on the influence of depression on medical illness.

For more than 30 years, he has been an active member of the American Psychiatric Association and its Council on Psychosomatic Medicine. In addition, Dr. Boland served as the chair for the Psychiatry Residency Review Committee for the Accreditation Council and is a former president of the American Association of Directors of Psychiatric Residency Training.

What makes us different?

• Instant Download

• Always Competitive Pricing

• 100% Privacy

• FREE Sample Available

• 24-7 LIVE Customer Support